Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Moodys
Julphar
Citi
Mallinckrodt
Fish and Richardson

Generated: March 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Daratumumab

« Back to Dashboard

US Patents for Daratumumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Daratumumab ➤ Try a Free Trial Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Try a Free Trial
Daratumumab ➤ Try a Free Trial Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts Advenchen Pharmaceuticals, LLC (Moorpark, CA) ➤ Try a Free Trial
Daratumumab ➤ Try a Free Trial Blocking CD38 using anti-CD38 F(ab')2 to protect NK cells The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) Janssen Biotech, Inc. (Spring House, PA) ➤ Try a Free Trial
Daratumumab ➤ Try a Free Trial Protein formulations containing amino acids Excelse Bio, Inc. (Thousand Oaks, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Daratumumab

Drugname Country Document Number Estimated Expiration Related US Patent
Daratumumab Canada 2900764 2033-02-08 ➤ Try a Free Trial
Daratumumab European Patent Office 2954056 2033-02-08 ➤ Try a Free Trial
Daratumumab Hong Kong 1218930 2033-02-08 ➤ Try a Free Trial
Daratumumab Japan 2016509014 2033-02-08 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Accenture
McKesson
Boehringer Ingelheim
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.